Schisandrin

Schisandrin is a bioactive lignan compound extracted from Schisandra chinensis berries that activates the Nrf2 antioxidant pathway. It demonstrates anti-inflammatory effects through modulation of gut microbiota and reduction of inflammatory cytokines in preclinical studies.

Origin & History

Schisandrin, a dibenzocyclooctadiene lignan, is derived from the fruits of Schisandra chinensis, a plant native to East Asia. It is extracted using solvent methods like ethanol or methanol reflux and further purified via chromatography.

Historical & Cultural Context

Schisandrin has been used for over 2,000 years in Traditional Chinese Medicine as a tonic for the liver, kidneys, heart, and lungs. It is traditionally employed to treat insomnia, cough, and fatigue.[7][8]

Health Benefits

• Reduces disease activity and inflammation in ulcerative colitis models, shown in preclinical mouse studies.[1] • Upregulates Nrf2 pathway and reduces inflammation in COPD models, comparable to dexamethasone.[2] • Modulates gut microbiota and bile acids, contributing to intestinal health in animal studies.[1] • Protects lung function by reducing oxidative stress and cytokine levels in COPD mouse models.[2] • Exhibits antioxidant and anti-inflammatory properties, based on traditional and preclinical evidence.[7][8]

How It Works

Schisandrin upregulates the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway, enhancing cellular antioxidant defenses. It modulates gut microbiota composition and bile acid metabolism, contributing to reduced intestinal inflammation. The compound also inhibits pro-inflammatory cytokine production comparable to dexamethasone in respiratory inflammation models.

Scientific Research

No human clinical trials or meta-analyses specifically on Schisandrin were identified. The available evidence is limited to preclinical animal and cell studies, such as those on ulcerative colitis (PMC10481484) and COPD (PMID: 37400851).

Clinical Summary

Current evidence for schisandrin comes primarily from preclinical mouse studies investigating inflammatory conditions. Studies show reduced disease activity in ulcerative colitis models and anti-inflammatory effects in COPD models with potency comparable to dexamethasone. Animal studies demonstrate beneficial modulation of gut microbiota and bile acid profiles. Human clinical trials are needed to establish therapeutic efficacy and optimal dosing protocols.

Nutritional Profile

Schisandrin is a dibenzocyclooctadiene lignan (molecular formula C₂₄H₃₂O₇, MW ~432.51 g/mol) and is one of the principal bioactive constituents of Schisandra chinensis (five-flavor berry) fruit. It is not a macronutrient source and is relevant purely as a bioactive phytochemical. Key details: • **Chemical class:** Dibenzocyclooctadiene lignan; also known as Schisandrin A or Wuweizisu A. • **Typical concentration in source material:** Schisandra chinensis dried fruit contains approximately 0.2–1.2% total lignans by weight, of which schisandrin typically constitutes roughly 0.1–0.4% (1–4 mg/g dried berry), varying by cultivar, geography, and processing. Standardized Schisandra extracts may contain 2–9% schisandrin. • **Co-occurring bioactive lignans in Schisandra:** Schisandrin B (γ-schisandrin), Schisandrin C, Schisandrol A, Schisandrol B, Gomisin A, Gomisin N, and Deoxyschisandrin — collectively referred to as Schisandra lignans, often present at combined levels of 5–19 mg/g in standardized extracts. • **Macronutrients (of whole Schisandra berry, per 100 g dried):** Carbohydrates ~60–70 g, Protein ~3–5 g, Fat ~2–4 g, Dietary fiber ~10–15 g; these are not attributable to schisandrin itself. • **Micronutrients in whole berry matrix:** Vitamin C (~50–90 mg/100 g fresh fruit), Vitamin E, organic acids (citric, malic, tartaric — contributing to its characteristic sour/five-flavor profile), essential minerals including potassium, magnesium, manganese, zinc, and selenium in trace amounts. • **Other bioactive compounds in the berry matrix:** Polysaccharides (immunomodulatory, ~3–8% of dried weight), essential oils (sesquiterpenes, monoterpenes ~1–3%), flavonoids, and phenolic acids. • **Bioavailability notes:** Schisandrin is lipophilic (LogP ~3.8–4.2) and demonstrates moderate oral bioavailability in animal models (estimated ~20–35% in rats). It is absorbed primarily in the small intestine and undergoes extensive first-pass hepatic metabolism via CYP3A4 and CYP2C enzymes. Co-administration with lipid-based carriers or phospholipid complexes (phytosomes) significantly enhances absorption (up to 2–3 fold). Peak plasma concentration (Tmax) is typically reached within 1–2 hours post-oral dosing. Schisandrin is a known inhibitor of CYP3A4 and P-glycoprotein, which may influence the bioavailability of co-administered drugs. It distributes preferentially to the liver and kidneys. Metabolites include demethylated and hydroxylated forms, with biliary and renal excretion pathways. • **Typical supplemental dosing (as part of Schisandra extract):** 200–1000 mg standardized extract/day (delivering approximately 5–40 mg schisandrin), or 1.5–6 g dried fruit equivalent per day in traditional use. Pure schisandrin in research studies: 5–80 mg/kg in animal models; human-equivalent doses are considerably lower (~1–10 mg/kg).

Preparation & Dosage

Preclinical studies report oral doses of 20-80 mg/kg/day in mice for conditions like ulcerative colitis. No human dosage guidelines are established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Curcumin, Resveratrol, Quercetin, Green Tea Extract, Vitamin C

Safety & Interactions

Safety data for isolated schisandrin is limited, with most information derived from whole Schisandra chinensis berry studies. Potential drug interactions may occur due to effects on cytochrome P450 enzymes, though specific interactions with schisandrin alone are not well documented. Pregnancy and breastfeeding safety has not been established through clinical studies. Individuals with autoimmune conditions should consult healthcare providers before use due to immune system modulation effects.